Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Elizabeth M. Coser"'
Autor:
Elizabeth M. Coser, Juliana I. Aoki, Cristiele Saborito, Stephane de la Roca, João Paulo T. Brufatto, Rodrigo Angerami, Rafael F. Stelini, Paulo Eduardo N. F. Velho, Adriano C. Coelho
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 9, Iss 11, p 264 (2024)
In South America, cutaneous leishmaniasis is caused by several species of the parasite of the genus Leishmania. Here, we describe an imported case of cutaneous leishmaniasis acquired in Peru by a Brazilian patient during her travel to Iquitos. Infect
Externí odkaz:
https://doaj.org/article/45e68368ce7d4c6ba4081eed31a98168
Autor:
Bianca A. Ferreira, Gustavo de A. Santos, Elizabeth M. Coser, Juliana M. Sousa, Mônica E. A. Gama, Leônidas L. B. Júnior, Fabrício S. Pessoa, Mayara I. S. Lima, Silvia R. B. Uliana, Adriano C. Coelho
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 8, Iss 7, p 354 (2023)
The parasitic protozoan Leishmania (Leishmania) infantum is the etiological agent of human visceral leishmaniasis in South America, an infectious disease associated with malnutrition, anemia, and hepatosplenomegaly. In Brazil alone, around 2700 cases
Externí odkaz:
https://doaj.org/article/40d3023b64144b27a3ad2ccd078d2c48
Autor:
Elizabeth M. Coser, Bianca A. Ferreira, Nilson Branco, Edite H. Yamashiro-Kanashiro, José Angelo L. Lindoso, Adriano C. Coelho
Publikováno v:
International Journal for Parasitology: Drugs and Drug Resistance, Vol 14, Iss , Pp 91-98 (2020)
Paromomycin is an aminoglycoside antibiotic approved in 2006 for the treatment of visceral leishmaniasis caused by Leishmania donovani in Southeast Asia. Although this drug is not approved for the treatment of visceral and cutaneous leishmaniasis in
Externí odkaz:
https://doaj.org/article/211ec30b222d4b878a59ea702a2a5541
Autor:
Bianca A. Ferreira, Thaynan F. C. Martins, Elizabeth M. Coser, Viviane da L. Oliveira, Edite H. Yamashiro-Kanashiro, Mussya C. Rocha, Marcelo M. Pinto, Paulo C. Cotrim, Adriano C. Coelho
Publikováno v:
Parasitology Research. 121:2683-2695
Autor:
Bianca A. Ferreira, Elizabeth M. Coser, Cristiele Saborito, Edite H. Yamashiro-Kanashiro, José Angelo L. Lindoso, Adriano C. Coelho
Publikováno v:
Experimental Parasitology. 246:108462
Autor:
E. H. Yamashiro-Kanashiro, Bianca A. Ferreira, Adriano C. Coelho, José Angelo Lauletta Lindoso, Elizabeth M. Coser
Publikováno v:
Acta tropica. 215
Treatment of tegumentary leishmaniasis in Brazil is limited to pentavalent antimonial, amphotericin B and pentamidine. These drugs, administered parenterally, cause several side effects and have a varied clinical response, depending on the species of
Autor:
Bianca Ferreira, Edite Hatsumi Yamashiro Kanashiro, Adriano C. Coelho, Paulo Cesar Cotrim, Elizabeth M. Coser, Mussya Cisotto Rocha
Publikováno v:
Resumos do....
Visceral leishmaniasis is a parasitic disease caused by the protozoan parasite L. (L.) infantum. The disease is the most severe clinical form of leishmaniasis that can lead to death if it is not treated. In Brazil, about 3,000 new cases of the diseas
Autor:
Cristiele da Silva, Elizabeth M. Coser, Adriano C. Coelho, Edite Hatsumi Yamashiro Kanashiro, José Angelo Lauletta Lindoso
Publikováno v:
Resumos do....
Tegumentary leishmaniasis is a disease caused by a protozoan parasite belonging to the genus Leishmania. This disease can occur by four different forms: localized cutaneous, disseminated cutaneous, mucocutaneous or diffuse cutaneous. In Brazil, tegum
Autor:
Bianca A Ferreira, Elizabeth M Coser, Stephane de la Roca, Juliana I Aoki, Nilson Branco, Gustavo H C Soares, Mayara I S Lima, Adriano C Coelho
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 18, Iss 5, p e0012175 (2024)
In Brazil, Leishmania amazonensis is the etiological agent of cutaneous and diffuse cutaneous leishmaniasis. The state of Maranhão in the Northeast of Brazil is prevalent for these clinical forms of the disease and also has high rates of HIV infecti
Externí odkaz:
https://doaj.org/article/2d46fcd420784ebaa31a975aafe67bec